Penumbra Inc - Asset Resilience Ratio
Penumbra Inc (PEN) has an Asset Resilience Ratio of 26.96% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PEN liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2024)
This chart shows how Penumbra Inc's Asset Resilience Ratio has changed over time. See PEN net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Penumbra Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Penumbra Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $321.03 Million | 18.4% |
| Short-term Investments | $149.27 Million | 8.56% |
| Total Liquid Assets | $470.30 Million | 26.96% |
Asset Resilience Insights
- Very High Liquidity: Penumbra Inc maintains exceptional liquid asset reserves at 26.96% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Penumbra Inc Industry Peers by Asset Resilience Ratio
Compare Penumbra Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055 |
Medical Devices | 4.92% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 22.31% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
Annual Asset Resilience Ratio for Penumbra Inc (2013–2024)
The table below shows the annual Asset Resilience Ratio data for Penumbra Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 22.18% | $340.13 Million | $1.53 Billion | +3.60pp |
| 2023-12-31 | 18.58% | $289.19 Million | $1.56 Billion | +4.87pp |
| 2022-12-31 | 13.72% | $188.03 Million | $1.37 Billion | -6.77pp |
| 2021-12-31 | 20.48% | $254.88 Million | $1.24 Billion | -11.70pp |
| 2020-12-31 | 32.18% | $264.83 Million | $822.98 Million | +3.74pp |
| 2019-12-31 | 28.44% | $189.39 Million | $665.90 Million | -10.57pp |
| 2018-12-31 | 39.01% | $200.89 Million | $515.01 Million | -6.01pp |
| 2017-12-31 | 45.02% | $214.59 Million | $476.67 Million | +3.25pp |
| 2016-12-31 | 41.77% | $128.75 Million | $308.25 Million | -7.22pp |
| 2015-12-31 | 48.99% | $129.26 Million | $263.85 Million | +9.24pp |
| 2014-12-31 | 39.75% | $48.25 Million | $121.38 Million | +26.34pp |
| 2013-12-31 | 13.42% | $9.54 Million | $71.15 Million | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also… Read more